Bioresorbable Vascular Scaffold: A Focused Review on Development and Preclinical Studies.
10.3969/j.issn.1671-7104.2018.02.010
- Author:
Linnan KE
1
;
Yuanli HUANG
1
;
Li LIU
1
;
Xiaojie DUAN
1
;
Xiaoming FENG
1
;
Chunren WANG
1
Author Information
1. National Institute for Food and Drug Control, Beijing, 102629.
- Publication Type:Journal Article
- Keywords:
bioresorbable vascular scaffold;
coronary artery disease;
preclinical studies;
safety and efficacy
- MeSH:
Absorbable Implants;
Animals;
Coronary Artery Disease;
Drug-Eluting Stents;
Percutaneous Coronary Intervention;
Prosthesis Design;
Stents;
Tissue Scaffolds;
Treatment Outcome
- From:Chinese Journal of Medical Instrumentation
2018;42(2):115-118
- CountryChina
- Language:Chinese
-
Abstract:
Bioresorbable vascular scaffolds(BVS) are new treatment strategies of percutaneous coronary intervention. They have been introduced to overcome limitations of bare metal stents (BMS) and drug-eluting stents(DES), since they provide temporary scaffolding and then disappear, liberate the treated vessel from cage. In this article, we review the current status and problems of BVS, various tests required before gaining regulatory approval for clinical use.
